Last reviewed · How we verify

NCT05911737

Ocular Parameters in Patients With Sleep Apnea

Status unknown Last updated 22 June 2023
What this trial tests

trial testing Short video and Questionnaire in Sleep Apnea Syndrome, Obstructive in 100 participants. Status unknown.

Timeline
1 July 2022
Primary endpoint
1 February 2024
1 July 2024

Quick facts

Lead sponsorDemocritus University of Thrace
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 July 2022
Primary completion1 February 2024
Estimated completion1 July 2024
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Democritus University of Thrace

Who can join

Adults 18 to 70, any sex, with Sleep Apnea Syndrome, Obstructive or Drowsiness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the ocular parameters of drowsiness in patients with diagnosed Obstructive Sleep Apnea Syndrome through objective methods of ocular imaging and subjective evaluation methods (questionnaire)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sleep Apnea Syndrome, Obstructive

Currently open trials in the same condition.

Other Democritus University of Thrace trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05911737.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing